These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16802626)

  • 1. New antibiotics for Gram-positive infections.
    Bradley JS
    Adv Exp Med Biol; 2006; 582():151-65. PubMed ID: 16802626
    [No Abstract]   [Full Text] [Related]  

  • 2. New antibiotics against gram-positives: present and future indications.
    Morata L; Mensa J; Soriano A
    Curr Opin Pharmacol; 2015 Oct; 24():45-51. PubMed ID: 26232669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer developments in the treatment of Gram-positive infections.
    Koomanachai P; Crandon JL; Nicolau DP
    Expert Opin Pharmacother; 2009 Dec; 10(17):2829-43. PubMed ID: 19929705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Daptomycin: a new therapeutic option for infections caused by Gram-positive bacteria. Introduction].
    Almirante B; Cantón R
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():1. PubMed ID: 21477696
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2004 Sep; 18(3):651-68, x. PubMed ID: 15308280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study proposes antibiotics as possible new treatment for some types of chronic low back pain.
    Wise J
    BMJ; 2013 May; 346():f2988. PubMed ID: 23661163
    [No Abstract]   [Full Text] [Related]  

  • 7. [Teicoplanin. New treatment potentials for gram-positive infections in the hospital].
    Iakovlev SV
    Antibiot Khimioter; 1999; 44(2):3-7. PubMed ID: 10202550
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial combinations in the treatment of gram-positive infections.
    Cruciani M; Concia E; Danzi MC; Bassetti D
    J Chemother; 1989 Jul; 1(4 Suppl):711-2. PubMed ID: 16312602
    [No Abstract]   [Full Text] [Related]  

  • 9. New treatments for multiply drug-resistant Gram-positive bacteria.
    Moellering RC
    J Infect; 2009 Sep; 59 Suppl 1():S1-3. PubMed ID: 19766884
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyogenic liver abscess. Its exclusive treatment with antibiotics].
    Montero E; Miquel J; Sáiz E; Alvarez JL
    Rev Clin Esp; 1992 May; 190(9):479-80. PubMed ID: 1626100
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of linezolid versus comparator therapies in Gram-positive infections.
    Wilcox MH
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii27-35. PubMed ID: 12730140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel antibiotics active against Gram-positive bacteria].
    Garcia Sánchez JE; Fresnadillo Martínez MJ
    Rev Esp Quimioter; 2000 Dec; 13(4):344-51. PubMed ID: 11498700
    [No Abstract]   [Full Text] [Related]  

  • 13. [Daptomycin in infections caused by gram-positive bacteria. Introduction].
    Pachón J; Cercenado E
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():1-2. PubMed ID: 22541968
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
    Nailor MD; Sobel JD
    Infect Dis Clin North Am; 2009 Dec; 23(4):965-82, ix. PubMed ID: 19909893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glycopeptides and therapy of infections caused by multiresistant Gram-positive organisms].
    Svetukhin AM; Blatun LA; Ukhin SA; Smirnova LB
    Antibiot Khimioter; 2004; 49(2):29-37. PubMed ID: 15285411
    [No Abstract]   [Full Text] [Related]  

  • 16. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
    Kern WV
    Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
    Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
    Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections].
    Iakovlev VP
    Antibiot Khimioter; 1999; 44(10):22-7. PubMed ID: 10635418
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.